Results 21 to 30 of about 1,077,596 (289)

An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses – A meeting report

open access: yesPreventive Medicine Reports, 2023
The 12th HPV Prevention and Control meeting was held on June 2–3, 2022, in Antwerp, Belgium. This technical meeting focused on several topics. This report summarises the discussions and lessons learned on two topics: an update on one-dose HPV vaccination
Dur-e-Nayab Waheed   +10 more
doaj   +1 more source

Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania. [PDF]

open access: yes, 2012
BACKGROUND: Cervical cancer is the leading cause of female cancer-related deaths in Tanzania. Vaccination against human papillomavirus (HPV) offers a new opportunity to control this disease.
Quentin, Wilm   +9 more
core   +5 more sources

As Vacinas Salvam Vidas? Sim, Salvam!

open access: yesActa Médica Portuguesa, 2014
Desde a sua introdução e aplicação universal, as vacinas têm sido utilizadas com sucesso reduzindo a morbilidade e mortalidade das doenças às quais se destinam, ao nível individual e através da imunidade de rebanho (imunidade colectiva).
Tinne Lernout   +3 more
doaj   +1 more source

Influence of the COVID-19 pandemic and social media on the behaviour of pregnant and lactating women towards vaccination: a scoping review

open access: yesBMJ Open, 2023
Background Pregnant women, foetuses and infants are at risk of infectious disease-related complications. Maternal vaccination is a strategy developed to better protect pregnant women and their offspring against infectious disease-related morbidity and ...
Pierre Van Damme   +5 more
doaj   +1 more source

Virus-Like Particle-Mediated Vaccination against Interleukin-13 May Harbour General Anti-Allergic Potential beyond Atopic Dermatitis [PDF]

open access: yes, 2020
Virus-like particle (VLP)-based anti-infective prophylactic vaccination has been established in clinical use. Although validated in proof-of-concept clinical trials in humans, no VLP-based therapeutic vaccination against self-proteins to modulate chronic
Foerster, John, Molęda, Aleksandra
core   +2 more sources

Vaccination against Foot-and-mouth disease : do initial conditions affect its benefit? [PDF]

open access: yes, 2013
When facing incursion of a major livestock infectious disease, the decision to implement a vaccination programme is made at the national level. To make this decision, governments must consider whether the benefits of vaccination are sufficient to ...
A Bouma   +38 more
core   +9 more sources

Impact of communicative and informative strategies on influenza vaccination adherence and absenteeism from work of health care professionals working at the university hospital of palermo, Italy: A quasi-experimental field trial on twelve influenza seasons [PDF]

open access: yes, 2019
Every year, about 20% of health care workers (HCWs) acquire influenza, continuing to work and encouraging virus spreading. Influenza vaccination coverage rates and absenteeism from work among HCWs of the University Hospital (UH) of Palermo were analyzed ...
Bono S.   +8 more
core   +1 more source

Increasing uptake of influenza vaccine by pregnant women post H1N1 pandemic: a longitudinal study in Melbourne, Australia, 2010 to 2014 [PDF]

open access: yes, 2015
Background: A Melbourne (Australia) university affiliated, tertiary obstetric hospital provides lay and professional education about influenza vaccine in pregnancy annually each March, early in the local influenza season.
McCarthy, Elizabeth Anne   +4 more
core   +3 more sources

Parenteral vaccination of mammalian livestock with Newcastle disease virus-based vector vaccines offers optimal efficacy and safety [PDF]

open access: yes, 2011
Newcastle disease virus (NDV) is an avian virus that is being evaluated as a vaccine vector for the delivery of foreign genes in mammals. The use of NDV as a vaccine vector in these species offers two major advantages.
Antonis, A.F.G.   +3 more
core   +2 more sources

Safety and tolerability of Meningococcus B vaccine in patients with chronical medical conditions (CMC)

open access: yesItalian Journal of Pediatrics, 2019
Background Invasive meningococcal disease is a serious global health threat in the world; in 2016, the European Centre for Disease Control and Prevention reported 3280 confirmed cases (including 304 deaths) of Invasive Meningococcal Diseases in Europe ...
L. Nicolosi   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy